| 发明名称 |
HLA-A24-RESTRICTED CANCER ANTIGEN PEPTIDE |
| 摘要 |
It is intended to provide an HLA-A24-restricted peptide originating in WT1 which has an activity of inducing CTL in vivo; a polynucleotide encoding thi s peptide; a cancer vaccine using the above peptide or polypeptide in vivo or in vitro; etc. The above cancer vaccine is usable in treating a large number of patients suffering from cancer.
|
| 申请公布号 |
CA2489227(A1) |
申请公布日期 |
2003.12.24 |
| 申请号 |
CA20032489227 |
申请日期 |
2003.06.12 |
| 申请人 |
CHUGAI SEIYAKU KABUSHIKI KAISHA;SUGIYAMA, HARUO;SUMITOMO PHARMACEUTICALS COMPANY, LIMITED |
发明人 |
TAKASU, HIDEO;GOTOH, MASASHI;SUGIYAMA, HARUO |
| 分类号 |
A61K38/00;A61K39/00;A61P35/00;C07K7/06;C07K7/08;C07K14/47;C12N1/19;C12N1/21;C12N15/12;(IPC1-7):C12N15/12;C12P21/02;C12N5/10;A61K38/17;C07K16/32;A61K39/395;A61K31/708;C07K14/82 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
